COMPARATIVE ANALYSIS OF CYP3A EXPRESSION IN HUMAN LIVER SUGGESTS ONLY A MINOR ROLE FOR CYP3A5 IN DRUG METABOLISM

Westlind-Johnsson, Anna, Malmebo, Sarah, Johansson, Anna, Otter, Charlotta, Andersson, Tommy B., Johansson, Inger, Edwards, Robert J., Boobis, Alan R., Ingelman-Sundberg, Magnus·2003·Drug Metabolism and Disposition
DOI 10.1124/dmd.31.6.755

Cited by (256)

Items 201–256 of 256

  1. Contrasting exome constancy and regulatory region variation in the gene encoding CYP3A4
    Olivia J. Creemer, Naser Ansari‐Pour, Rosemary Ekong, Ayele Tarekegn, Christopher A. Plaster, Ripudaman K. Bains, Yuval Itan, Endashaw Bekele, Neil N Bradman · 2016 · Pharmacogenetics and Genomics
  2. Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma
    Yonggang Wang, Chang Wang, Yanqiao Zhang, Jiqing Hao, Nong Yang, Jvfeng Wang, Min Peng, Tianshu Liu, Guifang Zhang, Xianbao Zhan et al. · 2022 · Frontiers in Oncology
  3. Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White Adults
    Ramesh Boinpally, Brian McNamee · 2025 · Neurology and Therapy
  4. mRNA expression levels of cytochrome P450 CYP1A2 , CYP3A4 , and CYP3A5 in the epidermis: a focus on individual differences among Japanese individuals
    Hiroko Makihara, Mika Maezawa, Kazusa Kaiga, Toshihiko Satake, Mayu Muto, Yui Tsunoda, Tsutomu Shimada, Tomoko Akase · 2024 · Xenobiotica
  5. Introduction to Clinical Pharmacology
    Rommel G. Tirona, Richard B. Kim · 2009 · Elsevier eBooks
  6. CYP3A5 is Unlikely to Mediate Anticancer Drug Resistance in Hepatocellular Carcinoma
    Volker Martin Lauschke, Åsa Nordling, Yitian Zhou, Sara Fontalva, Isabel Barragán, Magnus Ingelman‐Sundberg · 2019 · Pharmacogenomics
  7. Metabolisme av midazolam via CYP3A4 og CYP3A5 in vitro : utvikling av LC/MS-metode for analyse av hydroksylerte metabolitter
    Lillian Wåge Postvoll · 2006 · NORA - Norwegian Open Research Archives
  8. Therapeutic Drug Monitoring: A New Hope for Individualised Treatment with Venetoclax
    Yue Tang, Shuojiao Li, Peng Rao, Wenxian Yu, Xuanpeng Jiang, Jiatao Liu · 2025 · Current Drug Targets
  9. Research on the content and activity of CYP450 enzymes in human liver
    Cunzhen Zhang, Yan Fang, Lin-Jing Jia, Hai–Ling Qiao · 2025 · Drug Metabolism Reviews
  10. Pharmacokinetics of Ubrogepant in Healthy Japanese and White Adults
    Ramesh Boinpally, Joel M. Trugman · 2024 · Clinical Pharmacology in Drug Development
  11. PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?
    Justine Henriot, André Dallmann, François Dupuis, Jérémy Perrier, Sebastian Frechen · 2024 · CPT Pharmacometrics & Systems Pharmacology
  12. Study of CYP3A5 genetic polymorphism in Vietnamese Kinh ethnic group
    Nhung Phuong Vu, Nguyễn Đăng Tôn, Nguyễn Hải Hà · 2020 · TAP CHI SINH HOC
  13. Chemotherapy in the Pediatric Patient
    Alex Sparreboom, William Edward Evans, Sharyn D. Baker · 2009 · Elsevier eBooks
  14. Administration of Vitamin D Metabolites Affects RNA Expression of Xenobiotic Metabolising Enzymes and Function of ABC Transporters in Rats
    Karoline Klumpp, Frauke Lange, Alexandra S. Muscher‐Banse, Nadine Schnepel, Kathrin Hansen, A. Lifschitz, Laura Maté, Mirja Rosmarie Wilkens · 2019 · Journal of Chemistry
  15. Genetically Polymorphic Cytochrome P450s and Transporters and Personalized Antimicrobial Chemotherapy
    Hong‐Guang Xie · 2011 · Molecular Microbiology
  16. Cytochrome P450 Polymorphisms
    Ulrich M. Zanger · 2012 · Encyclopedia of Drug Metabolism and Interactions
  17. Variability in Induction of Human Drug Metabolizing Enzymes
    Allan B. Okey · 2005 · Drugs and the pharmaceutical sciences
  18. The Impact of CYP3A4, COMT V158M, and OPRM A118G Gene Polymorphisms on the Effectiveness of Sufentanil in Labor Analgesia
    Huiqiong Huang, Yunhong Zhang, Junxiang Jia, Zhuanghui Zhu · 2025 · Journal of Visualized Experiments
  19. CYP3A5*3 Polymorphism May Influence the Concentration of Valproic Acid
    Yan Wang, Zhiping Li · 2017 · International Journal of Pharmacology
  20. Interplay of Drug Metabolizing Enzymes and ABC Transporter
    Walter Rudolf Jäger · 2009 · Methods and principles in medicinal chemistry
  21. Pharmacogenetic screening of docetaxel, irinotecan and fluoropyrimidines in cancer therapy
    Tessa M. Bosch · 2006 · Utrecht University Repository (Utrecht University)
  22. The role of CYP3A4/5 in alprazolam metabolism
    Annika Allqvist · 2010 · Figshare
  23. Uttrykk av CYP3A4 og CYP3A5 i magesekk-, tynntarm- og leverprøver fra overvektige personer
    Solveig Vist · 2010 · NORA - Norwegian Open Research Archives
  24. Content and Activity of Cytochrome P450 3A in Rat Brain Microsomes and Mitochondria
    Nouf Alshammari · 2022 · Chapman University Digital Commons (Chapman University)
  25. Role of CYP2C8 in the metabolism of montelukast and imatinib : Studies in vitro, in silico and in humans
    Anne M. Filppula · 2014 · Työväentutkimus Vuosikirja
  26. The Role of Cytochrome P450 3A Inducers and Inhibitors in the Metabolism and the Effects of Oxycodone
    Tuija H. Nieminen · 2010 · UTUPub (University of Turku)
  27. Towards a test tube liver for drug metabolism studies
    Brahim Achour · 2013 · Research Explorer (The University of Manchester)
  28. A bioinformatic and cell-based study on the mutation and regulation of human nuclear receptors and their target genes
    Liu, Ya · 2013 · RMIT Research Repository (RMIT University Library)
  29. Estudios de factores genéticos y ambientales que regulan el metabolismo de ebastina en voluntarios sanos
    Vizcaíno Jaén, María Sonia · 2013 · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
  30. Characteristics of cytochrome P450-catalysed drug metabolism with focus on a black Tanzanian population
    Agneta Wennerholm · 2003 · Figshare
  31. Les inhibiteurs "suicides" des Cytochromes P450: Etablissement d'une banque de données, mise au point d'un test de screening et étudesstructures-activité concernant des substrats furaniques du CYP 3A4.
    Elena Fontana · 2005 · OpenGrey (Institut de l'Information Scientifique et Technique)
  32. Studies on the clinical pharmacology of antiretroviral agents
    Filip Josephson · 2009 · Figshare
  33. Influence of CYP3A enzymes and ABC transporters on the activity of tyrosine kinase inhibitors in chronic myeloid leukemia
    Karin Skoglund · 2013 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  34. HEPATIC DRUG METABOLISM
    Weili Huang, Yvonne S. Lin, Donavon J. McConn, Justina C. Calamia, Rheem A. Totah, Nina Isoherranen, Mary Glodowski, Kenneth E. Thummel · 2004
  35. Cyclosporin A som hemmer av CYP3A4 og CYP3A5
    Ingrid Kristine Ohm · 2010 · NORA - Norwegian Open Research Archives
  36. Effects of cytochrome P450 enzyme inhibitors and inducers on the metabolism of S-ketamine
    Marko A. Peltoniemi · 2013 · UTUPub (University of Turku)
  37. Utvikling av en analysemetode for vinkristin i plasma
    Stine Hiller Eidnes · 2007 · NORA - Norwegian Open Research Archives
  38. Physiologic effects of cytochrome P450 3A activity
    Raymond C. Givens · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  39. Metabolisme av quetiapin via CYP3A4 og CYP3A5 in vitro
    Gry Vibeke Bakken · 2007 · NORA - Norwegian Open Research Archives
  40. Effect of Cytochrome P450 2D6 and 3A Enzyme Inhibition on the Metabolism of Oxycodone
    Juha Grönlund · 2011 · UTUPub (University of Turku)
  41. Farmakokinetisk betydning av sekvensvarianter i CYP3A4, CYP3A5, POR og PPARA
    Miriam Dahl · 2013 · NORA - Norwegian Open Research Archives
  42. TOOLS IN PHARMACOVIGILANCE IN PSYCHIATRY: THERAPEUTIC DRUG MONITORING, PHARMACOGENETIC TESTS AND DRUG-DRUG INTERACTIONS DATABASES
    Jaquenoud Sirot Eveline · 2011
  43. Role of CYP2C8 in the metabolism of montelukast and imatinib
    Anne M. Filppula · 2014
  44. Impact of CYP3A5 Genetic Polymorphism on the Biotransformation of Drugs and Environmental Toxins
    Landry K. Kamdem · 2006 · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG))
  45. Novel strategies for risk assessment of pyrrolizidine alkaloids
    Lu Chen · 2019
  46. Alternative testing strategy to quantify inter-species, inter-ethnic, and inter-individual variation in bioactivation and toxicity of food-borne alkenylbenzenes and pyrrolizidine alkaloids
    Jia Ning · 2019
  47. Regulation of CYP3A5 in Pancreatic Ductal Adenocarcinoma
    Jessica Hoyer · 2019
  48. Effect of phyllanthus amarus schum. & thonn. extract on the pharmacokinetics of midazolam in rabbits
    Putthaporn Kaewmeesri · 2013
  49. Clinical pharmacological approaches to optimize anticancer drug dosing
    Laura Molenaar‐Kuijsten · 2022
  50. Genotipus alapján történő CYP2C19 és CYP2D6 fenotípus becslés és klinikai alkalmazhatósága
    Ádám Kiss · 2020 · Eötvös Loránd Tudományegyetem
  51. Application of reaction phenotyping to address pharmacokinetic variability in patient populations
    R. Foti, Joseph M. Roesner, Joshua T. Pearson · 2023 · Elsevier eBooks
  52. Optimisation de l’administration des médicaments chez les enfants transplantés grâce à la pharmacocinétique de population
    Nastya Kassir · 2012
  53. Pharmacogenetics in metabolic diseases: The impact of cytochrome P450 variants on drug response
    Paulina Tymińska, Julia Frączek, Karolina Borówka, Grzegorz Machnik, Bogusław Okopień · 2026 · Journal of Applied Pharmaceutical Science
  54. CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone
    Florine M. Wiss, Christian Krieg, Markus L. Lampert, Henriette E. Meyer zu Schwabedissen, Céline K. Stäuble, Thorsten Mikoteit, Christian Imboden, Samuel Sebastian Allemann · 2026 · Journal of Clinical Psychopharmacology
  55. Omics biomarkers of antipsychotic efficacy and safety: focus on lurasidone
    A.E. Gareeva, Liliya Borodina, E. G. Mikhailova, P.A. Gindullina, Rinat G. Valinurov, И. Ф. Тимербулатов · 2026 · Pharmacogenetics and Pharmacogenomics
  56. Le dosage des cytochromes P450 (CYPs) humains par spectrométrie de masse : applications en toxicologie
    Ahmad Ali · 2014 · theses.fr (ABES)